Department of Cancer Immunology, Genentech, South San Francisco, United States; Institute of Biochemistry II, Goethe University, Frankfurt am Main, Germany
Erik Verschueren
Department of Microchemistry, Proteomics and Lipidomics, Genentech, South San Francisco, United States
Trent Hinkle
Department of Microchemistry, Proteomics and Lipidomics, Genentech, South San Francisco, United States
Department of Microchemistry, Proteomics and Lipidomics, Genentech, South San Francisco, United States; Khoury College of Computer Sciences, Northeastern University, Boston, United States
Patrick Chang
Department of Pathology, Genentech, South San Francisco, United States
Cecile Chalouni
Department of Pathology, Genentech, South San Francisco, United States
Shilpa Rao
Department of Oncology Bioinformatics, Genentech, South San Francisco, United States
Youngsu Kwon
Department of Translational Immunology, Genentech, South San Francisco, United States
Junghyun Lim
Department of Cancer Immunology, Genentech, South San Francisco, United States
Anand Kumar Katakam
Department of Pathology, Genentech, South San Francisco, United States
Khoury College of Computer Sciences, Northeastern University, Boston, United States; Department of Mathematical Sciences, Kent State University, Kent, United States
Olga Vitek
Khoury College of Computer Sciences, Northeastern University, Boston, United States
Mike Reichelt
Department of Pathology, Genentech, South San Francisco, United States
Yasin Senbabaoglu
Department of Oncology Bioinformatics, Genentech, South San Francisco, United States
Brent Mckenzie
Department of Translational Immunology, Genentech, South San Francisco, United States
John R Rohde
Department of Microbiology and Immunology, Dalhousie University, Halifax, Canada
Institute of Biochemistry II, Goethe University, Frankfurt am Main, Germany; Department of Infectious Diseases, Genentech, South San Francisco, United States
Donald S Kirkpatrick
Interline Therapeutics, South San Francisco, United States
Defective autophagy is strongly associated with chronic inflammation. Loss-of-function of the core autophagy gene Atg16l1 increases risk for Crohn’s disease in part by enhancing innate immunity through myeloid cells such as macrophages. However, autophagy is also recognized as a mechanism for clearance of certain intracellular pathogens. These divergent observations prompted a re-evaluation of ATG16L1 in innate antimicrobial immunity. In this study, we found that loss of Atg16l1 in myeloid cells enhanced the killing of virulent Shigella flexneri (S.flexneri), a clinically relevant enteric bacterium that resides within the cytosol by escaping from membrane-bound compartments. Quantitative multiplexed proteomics of murine bone marrow-derived macrophages revealed that ATG16L1 deficiency significantly upregulated proteins involved in the glutathione-mediated antioxidant response to compensate for elevated oxidative stress, which simultaneously promoted S.flexneri killing. Consistent with this, myeloid-specific deletion of Atg16l1 in mice accelerated bacterial clearance in vitro and in vivo. Pharmacological induction of oxidative stress through suppression of cysteine import enhanced microbial clearance by macrophages. Conversely, antioxidant treatment of macrophages permitted S.flexneri proliferation. These findings demonstrate that control of oxidative stress by ATG16L1 and autophagy regulates antimicrobial immunity against intracellular pathogens.